42.28MMarket Cap
LossP/E TTM
TCRX Financials
See TScan Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
TScan Therapeutics Inc Earnings Date
Latest Release
May 6, 2026
EPS / Forecast
-0.22/-0.17
Revenue / Forecast
982.00K/2.50M
Revenue(YoY)
10.32M
266.65%
Analyst Rating
BUY
2026/08/01
FAQs
What is the total revenue of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its total revenue reached 10.32M, with a year-on-year change of 2.82M.
What are the current assets of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its current assets were 157.21M, with a year-on-year change of -46.29.
What are the total assets of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its total assets of TScan Therapeutics Inc were 228.79M, with a year-on-year change of -38.35.
What are the total liabilities of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its total liabilities of TScan Therapeutics Inc were 105.67M, with a year-on-year change of -18.81.
What is the total equity of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its total equity of TScan Therapeutics Inc was 123.12M, with a year-on-year change of -48.91.
What is the net operating income of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its net operating income of TScan Therapeutics Inc was -133.81M, with a year-on-year change of 0.75.
What is the net investment of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its net investment of TScan Therapeutics Inc was 109.37M, with a year-on-year change of 307.88.
What is the net financing of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its net financing of TScan Therapeutics Inc was -336.00K, with a year-on-year change of -100.16.
What is the Earnings Per Share (EPS) of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.00, with a year-on-year change of 12.17.
What is the net income of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its net income was -129.77M, with a year-on-year change of -1.78.
What is the net margin of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its net profit margin was -1256.81, with a year-on-year change of 72.24.
What is the debt-to-asset ratio of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 14.22, with a year-on-year change of 64.55.
What is the Return on Equity (ROE) of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -71.28, with a year-on-year change of -9.53.
What is the Return on Assets (ROA) of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -43.26, with a year-on-year change of -9.13.
What is the operating profit of TScan Therapeutics Inc?
According to TScan Therapeutics Inc's FY2025 earnings report, its operating profit was -133.81M, with a year-on-year change of 0.75.